Abstract: An objective of the present invention is to provide low-molecular-weight compounds that can inhibit Src family kinases. The present invention relates to compounds represented by general formula (I) or pharmacologically acceptable salts thereof. In the formula, Ar1 is optionally substituted C6-10 arylene or 5- to 10-membered heteroarylene, and Ar2 is optionally substituted C6-10 aryl or 5- to 10-membered heteroaryl. R1 and R2 are defined as described in the specification.

Abstract: An objective of the present invention is to provide low-molecular-weight compounds that can inhibit Src family kinases. The present invention relates to compounds represented by general formula (I) or pharmacologically acceptable salts thereof. In the formula, Ar1 is optionally substituted C6-10 arylene or 5- to 10-membered heteroarylene, and Ar2 is optionally substituted C6-10 aryl or 5- to 10-membered heteroaryl. R1 and R2 are defined as described in the specification.

Abstract: A method for interfacing with an interactive program is provided. Images of an interface object and a motion controller disposed in a gameplay environment are captured, a tag defined on a surface of the interface object. The captured images are analyzed to identify the tag on the surface of the interface object. Movement of the interface object is tracked by tracking the tag. Augmented images are generated by replacing, in the captured images, the tag with a virtual object, wherein generating the augmented images includes processing the tracked movement of the interface object to define movement of the virtual object. The captured images are analyzed to identify a pointing direction of the motion controller in the gameplay environment. The pointing direction of the motion controller is processed to identify a selection of a portion of the virtual object. The augmented images are presented on a display.

Abstract: A method of incorporating an augmented reality video image into a virtual environment comprises detecting a state of a real-world control object captured in a video image and augmenting the video image responsive to the state of the control object. The method further includes calculating trajectory parameters for an action with respect to a local coordinate system of the video image, responsive to the state of the control object, and embedding the augmented video image within a 3D virtual environment. The method also includes calculating the trajectory parameters for the action with respect to a local co-ordinate system of the 3D virtual environment, and rendering a graphical effect corresponding to the action within the 3D virtual environment.

Abstract: A method for interfacing with an interactive program is provided. Images of an interface object and a motion controller disposed in a gameplay environment are captured, a tag defined on a surface of the interface object. The captured images are analyzed to identify the tag on the surface of the interface object. Movement of the interface object is tracked by tracking the tag. Augmented images are generated by replacing, in the captured images, the tag with a virtual object, wherein generating the augmented images includes processing the tracked movement of the interface object to define movement of the virtual object. The captured images are analyzed to identify a pointing direction of the motion controller in the gameplay environment. The pointing direction of the motion controller is processed to identify a selection of a portion of the virtual object. The augmented images are presented on a display.

Abstract: A method for interfacing with an interactive program is provided. The method includes: capturing images of first and second pages of a book object, the first and second pages being joined along a fold axis defined along a spine of the book; analyzing the captured images to identify a first tag on the first page and a second tag on the second page; tracking movement of the first and second pages by tracking the first and second tags, respectively; generating augmented images by replacing, in the captured images, the book object with a virtual book, the virtual book having a first virtual page corresponding to the first page of the book object, the virtual book having a second virtual page corresponding to the second page of the book object; rendering first and second scenes on the first and second virtual pages, respectively; and presenting the augmented images on a display.

Abstract: A method of augmented reality includes associating tint information with a predetermined graphical object, and receiving a video image of a real scene comprising a feature for detection. The method further includes detecting the feature in the video image of the real scene and selecting a graphical object responsive to the detected feature, and augmenting the video image with the selected graphical object. If the selected graphical object is the predetermined graphical object, the method further includes retrieving the tint information associated with the predetermined graphical object, and modifying the color balance of the video image responsive to the tint information.

Abstract: A method for treating cancer that includes administering a pharmaceutically effective amount of a composition containing a compound represented by formula (I) or a pharmacologically acceptable salt thereof. In the formula, A represents a 5- to 10-membered heteroaryl group, or a C6-10 aryl group; R1 and R2 independently represent H, OH, X, CN, NO2, a C1-4 haloalkyl group, a C1-6 alkyl group, or the like <R1 and R2 together form a (substituted) 3- to 10-membered heterocyclyl group or a (substituted) 5- to 10-membered heteroaryl group>; R3 represents H, a C1-5 alkyl group, a C6-10 aryl group, a C1-5 alkyl group, or a C1-4 haloalkyl group; and R4 represents H, X, a C1-3 alkyl group, a C1-4 haloalkyl group, OH, CN, NO2, or the like.

Abstract: A method for treating cancer that includes administering a pharmaceutically effective amount of a composition containing a compound represented by formula (I) or a pharmacologically acceptable salt thereof. In the formula, A represents a 5- to 10-membered heteroaryl group, or a C6-10 aryl group; R1 and R2 independently represent H, OH, X, CN, NO2, a C1-4 haloalkyl group, a C1-6 alkyl group, or the like <R1 and R2 together form a (substituted) 3- to 10-membered heterocyclyl group or a (substituted) 5- to 10-membered heteroaryl group>; R3 represents H, a C1-5 alkyl group, a C6-10 aryl group, a C1-5 alkyl group, or a C1-4 haloalkyl group; and R4 represents H, X, a C1-3 alkyl group, a C1-4 haloalkyl group, OH, CN, NO2, or the like.

Abstract: A compound represented by formula (I) or a pharmacologically acceptable salt thereof, which can inhibit a fibroblast growth factor receptor (FGFR) family kinase in cancer tissues. (In the formula, A represents a 5- to 10-membered heteroaryl group, or a C6-10 aryl group; R1 and R2 independently represent H, OH, X, CN, NO2, a C1-4 haloalkyl group, a C1-6 alkyl group, or the like <R1 and R2 together form a (substituted) 3- to 10-membered heterocyclyl group or a (substituted) 5- to 10-membered heteroaryl group>; R3 represents H, a C1-5 alkyl group, a C6-10 aryl group, a C1-5 alkyl group, or a C1-4 haloalkyl group; and R4 represents H, X, a C1-3 alkyl group, a C1-4 haloalkyl group, OH, CN, NO2, or the like.

Abstract: A method of augmented reality includes associating tint information with a predetermined graphical object, and receiving a video image of a real scene comprising a feature for detection. The method further includes detecting the feature in the video image of the real scene and selecting a graphical object responsive to the detected feature, and augmenting the video image with the selected graphical object. If the selected graphical object is the predetermined graphical object, the method further includes retrieving the tint information associated with the predetermined graphical object, and modifying the colour balance of the video image responsive to the tint information.

Abstract: A method for interfacing with an interactive program is provided. The method includes: capturing images of first and second pages of a book object, the first and second pages being joined along a fold axis defined along a spine of the book; analyzing the captured images to identify a first tag on the first page and a second tag on the second page; tracking movement of the first and second pages by tracking the first and second tags, respectively; generating augmented images by replacing, in the captured images, the book object with a virtual book, the virtual book having a first virtual page corresponding to the first page of the book object, the virtual book having a second virtual page corresponding to the second page of the book object; rendering first and second scenes on the first and second virtual pages, respectively; and presenting the augmented images on a display.

Abstract: A compound represented by formula (I) or a pharmacologically acceptable salt thereof, which can inhibit a fibroblast growth factor receptor (FGFR) family kinase in cancer tissues. (In the formula, A represents a 5- to 10-membered heteroaryl group, or a C6-10 aryl group; R1 and R2 independently represent H, OH, X, CN, NO2, a C1-4 haloalkyl group, a C1-6 alkyl group, or the like <R1 and R2 together form a (substituted) 3- to 10-membered heterocyclyl group or a (substituted) 5- to 10-membered heteroaryl group>; R3 represents H, a C1-5 alkyl group, a C6-10 aryl group, a C1-5 alkyl group, or a C1-4 haloalkyl group; and R4 represents H, X, a C1-3 alkyl group, a C1-4 haloalkyl group, OH, CN, NO2, or the like.